Will Cannabis Seeds Be Banned?<

Will Cannabis Genetics Be Banned?

A redefinition of hemp under federal law, scheduled to take effect Nov. 12, signals the loss of Farm Bill safeguards for numerous hemp-derived THC products across the country: low-dose beverages as well as THCA flower and delta-8 THC edibles, vapes and additional products sold at gas stops and smoke shops.

But the hemp ban also generates a major complication for the legal cannabis industry. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will likely continue in legal states, the changes threaten to shutter some seed banks and genetics companies, observers note, while causing supply-chain problems for cannabis cultivators and https://nativesusa.com/ (https://nativesusa.com) retailers.

"If this wording goes forward, we will need pop-up shops to offer seeds in each state where it's legal," Campanella said. "Which is why we're also providing clones and tissue cultivation, because that's not included in the bill."

When are cannabis seeds and clones prohibited to ship between state lines?

The new regulations categorize seeds depending on the THC potential of the mother plant. Genetic material such as seeds and clones are rendered illegal if the end product exceeds the threshold.

For now, seeds are still shipping under the 2018 Farm Bill's status quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis cultivators who fear supply chain disruptions if out-of-state access to genetics is prohibited.

Most of the cannabis industry remains mostly unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the way of an exception for seeds or a general moratorium, numerous seed providers will simply be shuttered come November, he added.

"We are functioning legally currently, but if that shifts, it will upend the legitimate licensed sector in every state," said Power, whose clientele includes seed suppliers as well as licensed business cultivators.

"Consumers are going to lose choice, and it will be a major shutdown for most people."

What are cannabis seed banks doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which strengthened cannabis supervision in that state while also restricting hemp-derived THC items to licensed cannabis retailers.

Formerly a seed bank, Silberhaze is now focused on the branding, preservation and IP protection of premium plant genetics.

That's because seed companies hoping to remain compliant in this new environment must have solid documentation, he said.

"You have to demonstrate where this material comes from, so it's very important to have documentation, even to the point where you have breeder names," Silber said.

"Small businesses will have to operate with better records and a better chain of possession," he added. "We need that documentation too, because we don't want to be dealing with shady sources."

To prevent seizures and other legal consequences, seed entrepreneurs must "get their affairs in order" before the new regulations take place, Silber said.

"Audit all your materials immediately, and categorize what you can," Silber said. "Take stock, document your lineage, preserve cultivator records, and organize any cannabinoid or terpene data you already have. If regulations change, you'll be in a much better position to comprehend what may be affected and make educated decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be required for businesses engaged in research.

But for the time being, seed houses can't enroll with the DEA like state-licensed medical cannabis businesses can. Such an option is not available to seed suppliers, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis law group in Cleveland.

"Genetics activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered therapeutic operators to offer seeds, clones or personal growing materials," he said.

"But that is different from the DEA establishing a freestanding seed supplier registration category."

Some genetics companies are currently changing operational practices to conform with the new law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants over 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we organize it against the viable-seed exclusion?

Ickes also understands confusion from clients who believed government rescheduling of medical marijuana would resolve their story with banking institutions. However, the recent regulatory language has shifted those conversations past the fundamentals of classification, he said.

"Financial institutions ask whether this particular revenue stream is lawful, whether it ties to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed supplier selling drug-type genetics can't answer the first question with the hemp definition. It has to refer to a legal state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed keep the cleaner story."

What's the future of cannabis genetics?

Campanella is part of a emerging coalition of fellow breeders, growers and researchers that's arguing seeds are better defined as agricultural inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement work elsewhere.

"How do you control something based on what it might become later?" said Campanella. "Our preference is to have that wording removed, or get seeds regulated by the USDA as a hemp product."

But in the interim, Campanella is reorganizing Brothers Grimm to function outside the scope of shifting federal oversight. The company plans to maintain its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a hedge against government prohibition of cannabis seeds.

As she explained: "If things evolve in a way where we can't concentrate on interstate shipping, we'll have additional resources to satisfy people's requirements without putting ourselves in trouble."